156 related articles for article (PubMed ID: 27346662)
41. Pre-engraftment graft-versus-host disease after allogeneic hematopoietic cell transplantation for acute leukemia.
Lee JH; Lee JH; Kim DY; Yun SC; Kim SD; Choi Y; Lee YS; Kang YA; Jeon MJ; Seol M; Lee KH
Eur J Haematol; 2011 Aug; 87(2):172-81. PubMed ID: 21599753
[TBL] [Abstract][Full Text] [Related]
42. Spontaneous subdural hematoma in a patient with Philadelphia chromosome-positive acute lymphoblastic leukemia with normal platelet count after dasatinib treatment.
Mustafa Ali MK; Sabha MM; Al-Rabi KH
Platelets; 2015; 26(5):491-4. PubMed ID: 25025538
[TBL] [Abstract][Full Text] [Related]
43. Allogeneic haematopoietic stem cell transplant in Philadelphia-positive acute lymphoblastic leukaemia.
Fielding AK; Goldstone AH
Bone Marrow Transplant; 2008 Mar; 41(5):447-53. PubMed ID: 17968326
[TBL] [Abstract][Full Text] [Related]
44. [Outcomes of haplotype allogeneic hematopoietic stem cell transplantation in 17 patients with Philadelphia chromosome-positive acute lymphoblastic leukemia].
Zhou J; Zhou H; Zhang R; Wu D
Zhonghua Xue Ye Xue Za Zhi; 2014 Feb; 35(2):170-2. PubMed ID: 24606664
[No Abstract] [Full Text] [Related]
45. Allogeneic hematopoietic stem cell transplantation for Philadelphia-positive acute lymphoblastic leukemia in children and adolescents: a retrospective multicenter study of the Italian Association of Pediatric Hematology and Oncology (AIEOP).
Fagioli F; Zecca M; Rognoni C; Lanino E; Balduzzi A; Berger M; Messina C; Favre C; Rabusin M; Lo Nigro L; Masetti R; Prete A; Locatelli F;
Biol Blood Marrow Transplant; 2012 Jun; 18(6):852-60. PubMed ID: 22019726
[TBL] [Abstract][Full Text] [Related]
46. Subdural Hematoma Associated with Dasatinib and Intrathecal Methotrexate Treatment in Philadelphia Chromosome-positive Acute Lymphoblastic Leukemia.
Ureshino H; Nishioka A; Kojima K; Kizuka H; Sano H; Shindo T; Kubota Y; Ando T; Kimura S
Intern Med; 2016; 55(18):2703-6. PubMed ID: 27629971
[TBL] [Abstract][Full Text] [Related]
47. A potential graft-versus-leukemia effect after allogeneic hematopoietic stem cell transplantation for patients with Philadelphia chromosome-positive acute lymphoblastic leukemia: results from the French Bone Marrow Transplantation Society.
Espérou H; Boiron JM; Cayuela JM; Blanchet O; Kuentz M; Jouet JP; Milpied N; Cahn JY; Faucher C; Bourhis JH; Michallet M; Tanguy ML; Vernant JP; Gabert J; Bordigoni P; Ifrah N; Baruchel A; Dombret H;
Bone Marrow Transplant; 2003 May; 31(10):909-18. PubMed ID: 12748668
[TBL] [Abstract][Full Text] [Related]
48. [Imatinib in combination with allogeneic hematopoietic stem cell transplantation improved the outcome of adult Philadelphia chromosome-positive acute lymphoblastic leukemia].
Cheng Z; Zhao L; Chen G; Wu D; Qiu H; Tang X; Fu C; Jin Z; Chen F; Xue S; Sun A
Zhonghua Xue Ye Xue Za Zhi; 2014 Feb; 35(2):114-9. PubMed ID: 24606651
[TBL] [Abstract][Full Text] [Related]
49. [Allogeneic hematopoietic transplantation with stem cells extracted from peripheral blood].
Kusminsky G; Foncuberta MC; Aversa L; Drelichman G; Freigeiro D; Burgos R; Irrazabal C; Gonzalez G; Dictar M; Niborski R; Kohan A; Sanchez Avalos JC
Medicina (B Aires); 2000; 60(2):179-87. PubMed ID: 10962806
[TBL] [Abstract][Full Text] [Related]
50. Management of Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL).
Ottmann OG; Pfeifer H
Hematology Am Soc Hematol Educ Program; 2009; ():371-81. PubMed ID: 20008223
[TBL] [Abstract][Full Text] [Related]
51. The longitudinal analysis of large granular lymphocytosis in patients with Philadelphia chromosome-positive leukemia treated with dasatinib.
Shimura Y; Horiike S; Tsutsumi Y; Hatsuse M; Okano A; Fuchida S; Kobayashi T; Matsumoto Y; Kuroda J; Kawata-Iida E; Uchiyama H; Uoshima N; Shimazaki C; Kaneko H; Kobayashi Y; Taniwaki M
Int J Hematol; 2015 Oct; 102(4):426-33. PubMed ID: 26267232
[TBL] [Abstract][Full Text] [Related]
52. Two Elderly Patients with Philadelphia Chromosome Positive Mixed Phenotype Acute Leukemia Who Were Successfully Treated with Dasatinib and Prednisolone.
Takata H; Ikebe T; Sasaki H; Miyazaki Y; Ohtsuka E; Saburi Y; Ogata M; Shirao K
Intern Med; 2016; 55(9):1177-81. PubMed ID: 27150875
[TBL] [Abstract][Full Text] [Related]
53. Hematopoietic stem cell transplant versus chemotherapy plus tyrosine kinase inhibitor in the treatment of pediatric Philadelphia chromosome-positive acute lymphoblastic leukemia (ALL).
Salami K; Alkayed K; Halalsheh H; Hussein AA; Riziq M; Madanat F
Hematol Oncol Stem Cell Ther; 2013 Mar; 6(1):34-41. PubMed ID: 23664604
[TBL] [Abstract][Full Text] [Related]
54. High alloreactivity of low-dose prophylactic donor lymphocyte infusion in patients with acute leukemia undergoing allogeneic hematopoietic cell transplantation with an alemtuzumab-containing conditioning regimen.
Liga M; Triantafyllou E; Tiniakou M; Lambropoulou P; Karakantza M; Zoumbos NC; Spyridonidis A
Biol Blood Marrow Transplant; 2013 Jan; 19(1):75-81. PubMed ID: 22871557
[TBL] [Abstract][Full Text] [Related]
55. Achievement of complete donor-type chimerism and remission with dasatinib in Philadelphia chromosome-positive ALL relapsing after allogeneic transplantation.
Conchon M; Sanabani SS; Bendit I; Serpa M; Filho UA; de Barros Ferreira P; Novaes MM; Saboya R; Llacer-Dorliac PE; Dulley FL
Bone Marrow Transplant; 2010 Jun; 45(6):1125-6. PubMed ID: 19855440
[No Abstract] [Full Text] [Related]
56. Retrospective analysis of Philadelphia chromosome-positive acute lymphoblastic leukemia treated with allogeneic hematopoietic stem cell transplant versus chemotherapy combined with tyrosine kinase inhibitor.
Togasaki E; Shono K; Onoda M; Yokota A
Leuk Lymphoma; 2015 Jan; 56(1):244-7. PubMed ID: 24730539
[No Abstract] [Full Text] [Related]
57. Rapid engraftment after allogeneic transplantation of density-enriched peripheral blood CD34+ cells in patients with advanced hematologic malignancies.
Cao TM; Kusnierz-Glaz C; Valone F; Stockerl-Goldstein KE; Hu WW; Johnston L; Blume KG; Strober S; Negrin RS
Cancer; 2001 Jun; 91(12):2205-13. PubMed ID: 11413507
[TBL] [Abstract][Full Text] [Related]
58. Second- and third-generation tyrosine kinase inhibitors for Philadelphia-positive adult acute lymphoblastic leukemia relapsing post allogeneic stem cell transplantation-a registry study on behalf of the EBMT Acute Leukemia Working Party.
Hirschbühl K; Labopin M; Houhou M; Gabellier L; Labussière-Wallet H; Lioure B; Beelen D; Cornelissen J; Wulf G; Jindra P; Tilly H; Passweg J; Niittyvuopio R; Bug G; Schmid C; Nagler A; Giebel S; Mohty M
Bone Marrow Transplant; 2021 May; 56(5):1190-1199. PubMed ID: 33293597
[TBL] [Abstract][Full Text] [Related]
59. Allogeneic hematopoietic stem cell transplantation in Philadelphia-negative adult ALL: myeloablative, non-myeloablative, and beyond.
Hwang YY; Mohty M; Chim CS
Hematology; 2015 Mar; 20(2):61-71. PubMed ID: 24993587
[TBL] [Abstract][Full Text] [Related]
60. Overall survival with ponatinib versus allogeneic stem cell transplantation in Philadelphia chromosome-positive leukemias with the T315I mutation.
Nicolini FE; Basak GW; Kim DW; Olavarria E; Pinilla-Ibarz J; Apperley JF; Hughes T; Niederwieser D; Mauro MJ; Chuah C; Hochhaus A; Martinelli G; DerSarkissian M; Duh MS; McGarry LJ; Kantarjian HM; Cortes JE
Cancer; 2017 Aug; 123(15):2875-2880. PubMed ID: 28387926
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
